Banca de DEFESA: CARLOS EDUARDO PIRES DE SOUSA

Uma banca de DEFESA de MESTRADO foi cadastrada pelo programa.
STUDENT : CARLOS EDUARDO PIRES DE SOUSA
DATE: 01/06/2022
TIME: 11:30
LOCAL: Em ambiente virtual Google Meet - meet.google.com/ydi-ukxc-qih
TITLE:

Quality improvement cycle in the prescription of antineoplastic drugs in a university hospital.

KEY WORDS:

Patient safety.  Antineoplastics agents. Total Quality Management

PAGES: 25
BIG AREA: Ciências da Saúde
AREA: Saúde Coletiva
SUBÁREA: Saúde Pública
SUMMARY:

Introduction: Antineoplastics are drugs used in the treatment of malignant neoplasms. In general, they have a narrow therapeutic index, with a high potential to cause adverse events and harm to the patient when there is an error in their use. The occurrence of adverse events due to unsafe health care is probably one of the main causes of death and disability in the world, with half of the damage being preventable. The most harmful errors are related to prescription and use of medications. Investments in patient harm reduction can lead to financial savings and better patient outcomes. Objective: To evaluate the effectiveness of an intervention in the quality of prescriptions for anticancer drugs in a Brazilian university hospital of reference in cancer treatment. Methodology: This is a study developed through a quasi-experimental design, of the before-after type, without a control group, with a quantitative approach, using a quality improvement cycle. The improvement cycle will be carried out in the following stages: 1) Identification and prioritization of the quality problem; 2) Analysis of the causes of the problem; 3) Elaboration of quality criteria; 4) Quality level assessment; 5) Quality improvement intervention; 6) Reassessment of the quality level. Prescription quality criteria were based on the specialized literature and on the institution's safety prescription protocol. To assess the level of quality of prescription of anticancer drugs, prescriptions of anticancer drugs will be randomly selected from medical records of cancer patients undergoing treatment and considering the rates of compliance with each criterion. After the initial assessment, a structured quality improvement intervention will be applied regarding the safe prescription of antineoplastics, followed by reassessments to be carried out immediately after the intervention and after six months, in order to assess whether there has been an improvement in quality and whether the improvement has been maintained over time, respectively.

BANKING MEMBERS:
Presidente - 2171948 - PAULO JOSE DE MEDEIROS
Interno - 1868020 - ZENEWTON ANDRÉ DA SILVA GAMA
Externo à Instituição - CARLOS FREDERICO L. BENEVIDES